Amino acid replacement: D229V.
A18365042T
D229V | WRNexo-PA; D230V | WRNexo-PB; D229V | WRNexo-PC
D229V
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
WRNexoD229V/WRNexoD229V flies have normal survival rates in response to camptothecin or topotecan treatment and are not sensitive to bleomycin.
WRNexoΔ/WRNexoD229V mutants do not have reduced hatching frequency or hydroxyurea sensitivity (except hatching frequency is significantly reduced when embryos are laid by WRNexoΔ females mated with WRNexoD229V/WRNexoΔ males).
Mitotic recombination rates are approximately doubled in WRNexoe04496/Df(3R)Exel6178 flies, compared to WRNexoe04496/WRNexoe04496; rates of recombination in WRNexoe04496/WRNexoD229V are much lower (though still higher than WRNexoe04496/+).
WRNexoD229V/WRNexoD229V mus81Nhe/mus81Nhe double mutants survive to adulthood and are healthy.